Activity of Type II RAF Inhibitor Tovorafenib in a Pediatric Patient With a Recurrent Spindle Cell Sarcoma Harboring a Novel SNX8-BRAF Gene Fusion

Detalles Bibliográficos
Autores principales: Offer, Katharine, McGuire, Michael T., Song, Kunchang, Goldfischer, Michael J., Davare, Monika A., Corless, Christopher L., Beadling, Carol, Neff, Tanaya, Cox, Michael C., Govinda Raju, Sandya, Blackman, Samuel C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2023
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581647/
https://www.ncbi.nlm.nih.gov/pubmed/37410972
http://dx.doi.org/10.1200/PO.23.00065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581647/
https://www.ncbi.nlm.nih.gov/pubmed/37410972
http://dx.doi.org/10.1200/PO.23.00065

Ejemplares similares